David A. Siegel Calyxt, Inc. Transaction History

Two Sigma Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.24 - $0.91 $34,032 - $129,038	-141,800 Reduced 60.96%	90,800 $22,000
Q1 2022 May 16, 2022	SELL	$1.02 - $2.46 $163,710 - $394,830	-160,500 Reduced 40.83%	232,600 $242,000
Q4 2021 Feb 14, 2022	BUY	$2.06 - $4.05 $538,278 - $1.06 Million	261,300 Added 198.25%	393,100 $837,000
Q3 2021 Nov 15, 2021	BUY	$3.18 - $5.08 $367,290 - $586,740	115,500 Added 708.59%	131,800 $444,000
Q2 2021 Aug 16, 2021	SELL	$3.83 - $6.31 $1,149 - $1,892	-300 Reduced 1.81%	16,300 $66,000
Q1 2021 May 17, 2021	BUY	$4.25 - $12.01 $70,550 - $199,366	16,600 New	16,600 $100,000

Ticker CLXT
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 46,792,100
Market Cap $913M
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.